|
Company Watch
Lupin to market Cefpodoxime Proxetil in France
Our News Bureau - Mumbai
 Lupin
with its French regulatory agent Venipharm has received the marketing approval
for generic Cefpodoxime Proxetil 100 mg tablets in France. Cefpodoxime Proxetil
is a cephalosporin antibiotic used to treat a variety of bacterial infections.
Lupin's Cefpodoxime Proxetil Tablets are the generic equivalent of Sanofi-Aventis's
Orelox Tablets. Sales of Orelox tablets in France are close to 75 million Euros
as per IMS and the patent expiry is August 2007. The French market is the biggest
European market for Cefpodoxime Proxetil.
"This is the first generic approval in France for Cefpodixime Proxetil
and Lupin's first significant approval in Europe. We will work with our partners
to ensure launch of this generic upon patent expiry. We expect a number of other
such approvals in Europe in the coming months," said Dr Kamal Sharma, Managing
Director, Lupin.
|
